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The authors reply: Mascitelli and Goldstein 
suggest that screening athletes only once during 
adolescence will not identify some persons who 
are predisposed to cardiomyopathy because the 
overt disease phenotype may not develop until 
early adulthood. They advocate serial evaluation 
with annual ECG, as mandated in Italy. Six of the 
eight deaths in our study were attributable to a 
cardiac cause in athletes who had had normal 
results on ECG and echocardiography at 16 years 
of age. Although we did not perform serial evalu-
ations to show the subsequent development of a 
cardiomyopathy, we agree that the concept of 
age-related penetrance of cardiomyopathies must 
be considered. Although these diseases are not 
expressed in many people during adolescence, 
intense exercise regimens may unmask the phe-
notype in susceptible athletes.1 In light of our 
findings, the English Football Association recom-
mends additional serial assessments with ECG at 
18, 20, and 25 years of age.
Aengevaeren and colleagues highlight the 
need for timely recognition and management of 
sudden cardiac death during exercise. We agree 
that screening is not an alternative to providing 
essential emergency-response facilities or early 
CPR and defibrillation. Furthermore, we think 
that appropriate CPR training and AED mainte-
nance are essential in organized sports.
Morita and Komuro raise the issue of family 
history and genetic analysis in the 6 athletes who 
died from inherited cardiac disorders despite a 
normal cardiac screening at 16 years of age. The 
English Football Association health question-
naire specifically asks about a family history of 
heart disease in persons younger than 50 years 
of age (Fig. S1 in the Supplementary Appendix of 
our article, available at NEJM.org). Since our 
findings, the questionnaire has been modified 
to also include a family history of inherited car-
diac disease. Molecular autopsies were not per-
formed in these athletes, although they are play-
ing an increasingly prominent role in investigating 
cases of sudden cardiac death in persons with a 
structurally normal heart.2 Sheikh et al. recently 
evaluated 100 athletes with T-wave inversion 
typical of cardiomyopathy but without features 
of cardiomyopathy on ECG.3 All the athletes 
underwent genetic analysis in addition to com-
prehensive clinical evaluation. Of these athletes, 
21 received a diagnosis of cardiomyopathy on 
the basis of clinical assessment alone, and 10 of 
these 21 athletes had a disease-causing gene 
mutation. Of the remaining 79 athletes with a 
normal phenotype, genetic testing identified 
only 2 athletes with pathogenic variants, and the 
cost of genetic testing was three times that of a 
clinical evaluation alone. Therefore, our practice 
is to limit genetic testing in athletes to those 
who have an obvious disease phenotype or a 
family member with proven inherited disease 
and a recognized pathogenic variant.
Aneil Malhotra, M.B., B.Chir., Ph.D. 
Sanjay Sharma, M.B., Ch.B., M.D.
St. George’s, University of London 
London, United Kingdom 
sasharma@ sgul . ac . uk
Since publication of their article, the authors report no fur-
ther potential conflict of interest.
1. James CA, Bhonsale A, Tichnell C, et al. Exercise increases 
age-related penetrance and arrhythmic risk in arrhythmogenic 
right ventricular dysplasia/cardiomyopathy-associated desmo-
somal mutation carriers. J Am Coll Cardiol 2013; 62: 1290-7.
2. Basso C, Burke M, Fornes P, et al. Guidelines for autopsy 
investigation of sudden cardiac death. Virchows Arch 2008; 452: 
11-8.
3. Sheikh N, Papadakis M, Wilson M, et al. Diagnostic yield of 
genetic testing in young athletes with T-wave inversion. Circula-
tion 2018 May 15 (Epub ahead of print).
DOI: 10.1056/NEJMc1813056
The New England Journal of Medicine 
Downloaded from nejm.org at ST GEORGES University on January 15, 2019. For personal use only. No other uses without permission. 
 Copyright © 2018 Massachusetts Medical Society. All rights reserved. 
